Abstract
We investigated the relationship between NT-ProBNP and mortality in a general population-based cohort. A total of 2021 out of 4650 participants from previously published HAPPY study were included. Mean follow-up was 84.5±10.4 months. After adjusting for risk factors, high levels of LogNT-proBNP predicted all-cause death (HR: 3.23; 95% CI: 2.20-4.75; p<0.001) and cardiovascular death (HR: 3.85; 95% CI: 2.37-6.26; p<0.001). Regression analysis revealed that LogNT-proBNP was an independent predictor of all-cause death (HR: 2.85; 95% CI: 1.91-4.24; p<0.001) and cardiovascular death (HR: 3.02; 95% CI: 1.84-4.95; p<0.001). Conclusıon: Our study showed that in long term follow-up, NT-proBNP is associated with increased all-cause and cardiovascular mortality.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
